Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor

Journal of Experimental Medicine

Volumn 204, Issue 13, 2007, Pages 3157-3172

  Alexander Brett, Jennifer M ^a   Fremont, Daved H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLYCOSAMINOGLYCAN; LYMPHOTACTIN; M3 CHEMOKINE DECOY RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CRYSTAL STRUCTURE; ELECTRICITY; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN;

BINDING, COMPETITIVE; CRYSTALLOGRAPHY, X-RAY; ELECTROSTATICS; ESCHERICHIA COLI; GLYCOSAMINOGLYCANS; HUMANS; KINETICS; LEUKOCYTES; LIGANDS; LYMPHOKINES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, MUSCARINIC M3; RECEPTORS, G-PROTEIN-COUPLED; SIALOGLYCOPROTEINS;

EID: 37549041251     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071677     Document Type: Article

References (70)

1. Murphy, P.M. 2002. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54:227-229.
2. Rollins, B.J. 1997. Chemokines. Blood. 90:909-928.
3. Linhardt, R.J., and T. Toida. 2004. Role of glycosaminoglycans in cellular communication. Acc. Chem. Res. 37:431-438.
4. Lortat-Jacob, H., A. Grosdidier, and A. Imberty. 2002. Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. USA. 99:1229-1234.
5. Proudfoot, A.E., T.M. Handel, Z. Johnson, E.K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T.N. Wells, and M.H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA. 100:1885-1890.
6. Johnson, Z., M.H. Kosco-Vilbois, S. Herren, R. Cirillo, V. Muzio, P. Zaratin, M. Carbonatto, M. Mack, A. Smailbegovic, M. Rose, et al. 2004. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173:5776-5785.
7. Alcami, A., and U.H. Koszinowski. 2000. Viral mechanisms of immune evasion. Immunol. Today. 21:447-455.
8. Lusso, P. 2000. Chemokines and viruses: the dearest enemies. Virology. 273:228-240.
9. Luster, A.D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445.
10. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3:36-50.
11. Graham, K.A., A.S. Lalani, J.L. Macen, T.L. Ness, M. Barry, L.Y. Liu, A. Lucas, I. Clark-Lewis, R.W. Moyer, and G. McFadden. 1997. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology. 229:12-24.
12. Carfi, A., C.A. Smith, P.J. Smolak, J. McGrew, and D.C. Wiley. 1999. Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc. Natl. Acad. Sci. USA. 96:12379-12383.
13. Seet, B.T., R. Singh, C. Paavola, E.K. Lau, T.M. Handel, and G. McFadden. 2001. Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc. Natl. Acad. Sci. USA. 98:9008-9013.
14. Arnold, P.L., and D.H. Fremont. 2006. Structural determinants of chemokine binding by an Ectromelia virus-encoded decoy receptor. J. Virol. 80:7439-7449.
15. Zhang, L., M. Derider, M.A. McCornack, S.C. Jao, N. Isern, T. Ness, R. Moyer, and P.J. LiWang. 2006. Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta. Proc. Natl. Acad. Sci. USA. 103:13985-13990.
16. Alejo, A., M.B. Ruiz-Arguello, Y. Ho, V.P. Smith, M. Saraiva, and A. Alcami. 2006. A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc. Natl. Acad. Sci. USA. 103:5995-6000.
17. Bryant, N.A., N. Davis-Poynter, A. Vanderplasschen, and A. Alcami. 2003. Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J. 22:833-846.
18. Wang, D., W. Bresnahan, and T. Shenk. 2004. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc. Natl. Acad. Sci. USA. 101:16642-16647.
19. Virgin, H.W., IV, P. Latreille, P. Wamsley, K. Hallsworth, K.E. Weck, A.J. Dal Canto, and S.H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904.
20. van Berkel, V., K. Preiter, H.W. Virgin IV, and S.H. Speck. 1999. Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein. J. Virol. 73:4524-4529.
21. van Berkel, V., J. Barrett, H.L. Tiffany, D.H. Fremont, P.M. Murphy, G. McFadden, S.H. Speck, and H.W. Virgin IV. 2000. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74:6741-6747.
22. van Berkel, V., B. Levine, S.B. Kapadia, J.E. Goldman, S.H. Speck, and H.W. Virgin IV. 2002. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J. Clin. Invest. 109:905-914.
23. Parry, C.M., J.P. Simas, V.P. Smith, C.A. Stewart, A.C. Minson, S. Efstathiou, and A. Alcami. 2000. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191:573-578.
24. Weinberg, J.B., M.L. Lutzke, S. Efstathiou, S.L. Kunkel, and R. Rochford. 2002. Elevated chemokine responses are maintained in lungs after clearance of viral infection. J. Virol. 76:10518-10523.
25. Sarawar, S.R., R.D. Cardin, J.W. Brooks, M. Mehrpooya, R.A. Tripp, and P.C. Doherty. 1996. Cytokine production in the immune response to murine gammaherpesvirus 68. J. Virol. 70:3264-3268.
26. Verzijl, D., C.P. Fitzsimons, M. Van Dijk, J.P. Stewart, H. Timmerman, M.J. Smit, and R. Leurs. 2004. Differential activation of murine herpesvirus 68- and Kaposi ' s sarcoma-associated herpesvirus-encoded ORF74 G protein-coupled receptors by human and murine chemokines. J. Virol. 78:3343-3351.
27. Alexander, J.M., C.A. Nelson, V. van Berkel, E.K. Lau, J.M. Studts, T.J. Brett, S.H. Speck, T.M. Handel, H.W. Virgin IV, and D.H. Fremont. 2002. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell. 111:343-356.
28. Lubkowski, J., G. Bujacz, L. Boque, P.J. Domaille, T.M. Handel, and A. Wlodawer. 1997. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat. Struct. Biol. 4:64-69.
29. Kuloglu, E.S., D.R. McCaslin, J.L. Markley, and B.F. Volkman. 2002. Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions. J. Biol. Chem. 277:17863-17870.
30. Paavola, C.D., S. Hemmerich, D. Grunberger, I. Polsky, A. Bloom, R. Freedman, M. Mulkins, S. Bhakta, D. McCarley, L. Wiesent, et al. 1998. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J. Biol. Chem. 273:33157-33165.
31. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675-705.
32. Schreiber, G., and A.R. Fersht. 1996. Rapid, electrostatically assisted association of proteins. Nat. Struct. Biol. 3:427-431.
33. Selzer, T., and G. Schreiber. 1999. Predicting the rate enhancement of protein complex formation from the electrostatic energy of interaction. J. Mol. Biol. 287:409-419.
34. Radic, Z., P.D. Kirchhoff, D.M. Quinn, J.A. McCammon, and P. Taylor. 1997. Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin. J. Biol. Chem. 272:23265-23277.
35. Lau, E.K., C.D. Paavola, Z. Johnson, J.P. Gaudry, E. Geretti, F. Borlat, A.J. Kungl, A.E. Proudfoot, and T.M. Handel. 2004. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 279:22294-22305.
36. Spillmann, D., D. Witt, and U. Lindahl. 1998. Defining the interleukin-8-binding domain of heparan sulfate. J. Biol. Chem. 273:15487-15493.
37. Webb, L.M., V.P. Smith, and A. Alcami. 2004. The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans. FASEB J. 18:571-573.
38. Peterson, F.C., E.S. Elgin, T.J. Nelson, F. Zhang, T.J. Hoeger, R.J. Linhardt, and B.F. Volkman. 2004. Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. J. Biol. Chem. 279:12598-12604.
39. Fernandez, E.J., and E. Lolis. 2002. Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 42:469-499.
40. Esko, J.D., J.L. Weinke, W.H. Taylor, G. Ekborg, L. Roden, G. Anantharamaiah, and A. Gawish. 1987. Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J. Biol. Chem. 262:12189-12195.
41. Skelton, N.J., C. Quan, D. Reilly, and H. Lowman. 1999. Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure. 7:157-168.
42. Hemmerich, S., C. Paavola, A. Bloom, S. Bhakta, R. Freedman, D. Grunberger, J. Krstenansky, S. Lee, D. McCarley, M. Mulkins, et al. 1999. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry. 38:13013-13025.
43. Nardese, V., R. Longhi, S. Polo, F. Sironi, C. Arcelloni, R. Paroni, C. DeSantis, P. Sarmientos, M. Rizzi, M. Bolognesi, et al. 2001. Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES. Nat. Struct. Biol. 8:611-615.
44. Chakravarty, L., L. Rogers, T. Quach, S. Breckenridge, and P.E. Kolattukudy. 1998. Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J. Biol. Chem. 273:29641-29647.
45. Campanella, G.S., E.M. Lee, J. Sun, and A.D. Luster. 2003. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J. Biol. Chem. 278:17066-17074.
46. Proudfoot, A.E., S. Fritchley, F. Borlat, J.P. Shaw, F. Vilbois, C. Zwahlen, A. Trkola, D. Marchant, P.R. Clapham, and T.N. Wells. 2001. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276:10620-10626.
47. Shaw, J.P., Z. Johnson, F. Borlat, C. Zwahlen, A. Kungl, K. Roulin, A. Harrenga, T.N. Wells, and A.E. Proudfoot. 2004. The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure. 12:2081-2093.
48. Rice, J., B. de Lima, F.K. Stevenson, and P.G. Stevenson. 2002. A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope. Eur. J. Immunol. 32:3481-3487.
49. Pyo, R., K.K. Jensen, M.T. Wiekowski, D. Manfra, A. Alcami, M.B. Taubman, and S.A. Lira. 2004. Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. Am. J. Pathol. 164:2289-2297.
50. Liu, L., E. Dai, L. Miller, B. Seet, A. Lalani, C. Macauley, X. Li, H.W. Virgin IV, C. Bunce, P. Turner, et al. 2004. Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models. Transplantation. 77:1652-1660.
51. Jensen, K.K., S.C. Chen, R.W. Hipkin, M.T. Wiekowski, M.A. Schwarz, C.C. Chou, J.P. Simas, A. Alcami, and S.A. Lira. 2003. Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J. Virol. 77:624-630.
52. Martin, A.P., J.M. Alexander-Brett, C. Canasto-Chibuque, A. Garin, J.S. Bromberg, D.H. Fremont, and S.A. Lira. 2007. The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J. Immunol. 178:4623-4631.
53. Marcaurelle, L.A., L.S. Mizoue, J. Wilken, L. Oldham, S.B. Kent, T.M. Handel, and C.R. Bertozzi. 2001. Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domain. Chemistry. 7:1129-1132.
54. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
55. Navaza, J., and P. Saludjian. 1997. AMoRe: An automated molecular replacement program package. Methods Enzymol. 276:581-594.
56. Terwilliger, T.C. 2004. Using prime-and-switch phasing to reduce model bias in molecular replacement. Acta Crystallogr. D Biol. Crystallogr. 60:2144-2149.
57. Jones, T.A., J.Y. Zou, S.W. Cowan, and M. Kjeldgaard. 1991. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:110-119.
58. Brunger, A.T., P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse-Kunstleve, J.S. Jiang, J. Kuszewski, M. Nilges, N.S. Pannu, et al. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905-921.
59. Kabsch, W. 1976. A solution for the best rotation to relate two sets of vectors. Acta Crystallogr. A. 32:922-923.
60. Lawrence, M.C., and P.M. Colman. 1993. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234:946-950.
61. Hubbard, S.J., S.F. Campbell, and J.M. Thornton. 1991. Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J. Mol. Biol. 220:507-530.
62. McDonald, I.K., and J.M. Thornton. 1994. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238:777-793.
63. Schuck, P. 1997. Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors. Curr. Opin. Biotechnol. 8:498-502.
64. Nieba, L., A. Krebber, and A. Pluckthun. 1996. Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. Anal. Biochem. 234:155-165.
65. Jason Wong, C., A.L. Lucius, and T.M. Lohman. 2005. Energetics of DNA end binding by E. coli RecBC and RecBCD helicases indicate loop formation in the 3′-single-stranded DNA tail. J. Mol. Biol. 352:765-782.
66. Zhang, L., D.L. Beeler, R. Lawrence, M. Lech, J. Liu, J.C. Davis, Z. Shriver, R. Sasisekharan, and R.D. Rosenberg. 2001. 6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J. Biol. Chem. 276:42311-42321.
67. Carson, M. 1997. Ribbons. Methods Enzymol. 277:493-502.
68. Nicholls, A., K.A. Sharp, and B. Honig. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:281-296.
69. Pettersen, E.F., T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, and T.E. Ferrin. 2004. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
70. Swaminathan, G.J., D.E. Holloway, R.A. Colvin, G.K. Campanella, A.C. Papageorgiou, A.D. Luster, and K.R. Acharya. 2003. Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine. Structure. 11:521-532.